Company intelligence / Profile preview

NGeneBioAI

Ownership: Private
Development stage: Commercial

Overview

NGeneBioAI provides advanced AI-powered proteomics and precision diagnostic data analysis services. It supports biomarker discovery, cancer genomics research, and enables early cancer diagnosis through its proprietary platforms. The company is building tools that unlock new features in mass spectrometry data for deeper biological insights.

Therapeutic areas: Oncology
Modalities: Diagnostic softwareData analysis platform
Industry: Digital Health Medical Devices

Partnerships

LabGenomics

Beyond the preview

Go deeper on NGeneBioAI.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NGeneBioAI.

Explore the full profile